In addition, up-regulation of miR-495 by E12/E47 in breast cancer stem cells promotes oncogenesis and hypoxia resistance via the down-regulation of E-cadherin and REDD1 (Hwang-Verslues et al., 2011). Here, DDIT4 is linked to breast cancer.